Valuation : Labcorp Holdings Inc.

Market Cap 26.51B 22.81B 21.46B 19.61B 36.68B 2,503B 36.78B 254B 98.42B 1,284B 99.55B 97.38B 4,137B P/E 2026 *
23.5x
P/E 2027 * 21x
Enterprise Value 31.62B 27.21B 25.6B 23.39B 43.75B 2,986B 43.87B 303B 117B 1,532B 119B 116B 4,935B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 2x
Free-Float
99.65%
Yield 2026 *
0.89%
Yield 2027 * 0.9%
1 day-1.39%
1 week-2.45%
Current month-1.73%
1 month+3.27%
3 months+23.28%
6 months+21.22%
Current year+30.30%
1 week 326.16
Extreme 326.16
336.65
1 month 315.33
Extreme 315.3302
341.8
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Free

Chief Technology Officer

3,000 0.0037%
9/1/26 A Free

Chief Technology Officer

750 0.0009%
9/1/26 A Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-2.45%+17.30%+59.77% 26.51B
+0.16%+0.59%+95.32%+465.83% 47.31B
+0.51%+0.26%-14.46%-36.89% 6.96B
-1.22%-1.21%+3.22%+138.24% 5.8B
+0.12%-2.84%+17.66%+67.78% 3.32B
-1.60%-0.40%-35.12%+1,849.89% 2.56B
-0.46%-3.71%+117.79%+21.88% 2.23B
+7.98%+6.89%+27.90%+41.05% 2.14B
+0.45%-2.63%-13.48%-54.02% 1.84B
+1.72%-0.58%+36.43%+212.03% 1.63B
Average +0.56%-0.53%+25.26%+276.56% 10.03B
Weighted average by Cap. -0.18%-0.65%+51.96%+294.27%

Financials

2026 *2027 *
Net sales 14.75B 12.69B 11.94B 10.91B 20.41B 1,393B 20.46B 141B 54.76B 714B 55.38B 54.18B 2,302B 15.47B 13.32B 12.53B 11.44B 21.41B 1,461B 21.47B 148B 57.44B 750B 58.11B 56.84B 2,415B
Net income 1.13B 973M 915M 836M 1.56B 107B 1.57B 10.81B 4.2B 54.76B 4.24B 4.15B 176B 1.24B 1.07B 1.01B 919M 1.72B 117B 1.72B 11.88B 4.61B 60.17B 4.66B 4.56B 194B
Net Debt 5.11B 4.4B 4.14B 3.78B 7.07B 483B 7.09B 48.91B 18.98B 248B 19.2B 18.78B 798B 4.41B 3.79B 3.57B 3.26B 6.1B 416B 6.11B 42.16B 16.36B 213B 16.55B 16.19B 688B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
04/09/26 $326.89 -1.39% 438,651
03/09/26 $331.50 -0.05% 520,645
02/09/26 $331.66 +1.24% 643,937
01/09/26 $327.61 -1.52% 571,750
31/08/26 $332.66 -0.73% 851,157
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
326.89USD
Average target price
341.50USD
Spread / Average Target
+4.47%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!